Chiesi, Marco Antonetto sign deal

Italian daily Il Corriere della Sera reported that Turin, Italy-based Marco Antonetto Farmaceutici is likely to be acquired by Chiesi Farmaceutici. The parties are reported to have already signed a distribution agreement likely to evolve into an acquisition. The agreement allows Chiesi to expand its business to OTCs and nutraceuticals. Chiesi is an Italy-based group with a sales volume of €1.55bn, and margins of €400m, which invested €236m in R&D in 2015-16. (Source Il Corriere della Sera)